Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Mullish

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 14, 2019
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese PatientsJessica R Allegretti, Zain Kassam, Benjamin H Mullish, et al.
Frontiers in Cellular and Infection Microbiology|September 13, 2021
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell TransplantationAndrew J Innes, Benjamin H Mullish, Rohma Ghani, et al.
Gut|August 30, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory <i>Clostridium difficile</i> infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelinesBenjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Gut|March 1, 2019
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent <i>Clostridioides difficile</i> infectionBenjamin H Mullish, Julie A K McDonald, Alexandros Pechlivanis, et al.
Scientific Reports|March 5, 2020
Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancyCaroline Ovadia, Alvaro Perdones-Montero, Hei Man Fan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2023
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseThomas Payne, Matthew Appleby, Ellen Buckley, et al.
Clinical and Translational Medicine|January 1, 2023
Faecal metabolite deficit, gut inflammation and diet in Parkinson's disease: Integrative analysis indicates inflammatory response syndromeAisha Augustin, Adrien Le Guennec, Chianna Umamahesan, et al.
Gut|April 12, 2024
The use of faecal microbiota transplant as treatment for recurrent or refractory <i>Clostridioides difficile</i> infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelinesBenjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Microorganisms|August 7, 2021
Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central IndiaTanya M Monaghan, Rima N Biswas, Rupam R Nashine, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 14, 2019
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese PatientsJessica R Allegretti, Zain Kassam, Benjamin H Mullish, et al.
Frontiers in Cellular and Infection Microbiology|September 13, 2021
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell TransplantationAndrew J Innes, Benjamin H Mullish, Rohma Ghani, et al.
Gut|August 30, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory <i>Clostridium difficile</i> infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelinesBenjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Gut|March 1, 2019
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent <i>Clostridioides difficile</i> infectionBenjamin H Mullish, Julie A K McDonald, Alexandros Pechlivanis, et al.
Scientific Reports|March 5, 2020
Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancyCaroline Ovadia, Alvaro Perdones-Montero, Hei Man Fan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2023
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseThomas Payne, Matthew Appleby, Ellen Buckley, et al.
Clinical and Translational Medicine|January 1, 2023
Faecal metabolite deficit, gut inflammation and diet in Parkinson's disease: Integrative analysis indicates inflammatory response syndromeAisha Augustin, Adrien Le Guennec, Chianna Umamahesan, et al.
Gut|April 12, 2024
The use of faecal microbiota transplant as treatment for recurrent or refractory <i>Clostridioides difficile</i> infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelinesBenjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Microorganisms|August 7, 2021
Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central IndiaTanya M Monaghan, Rima N Biswas, Rupam R Nashine, et al.
Pageof 15